WASHINGTON, D.C. –Today, June 8th, 2020, Representatives Brian Fitzpatrick (R-PA), James P.
WASHINGTON, D.C.—Today, June 8th, 2020, Representatives Brian Fitzpatrick (PA-01) and Conor Lamb (PA-17) introduced H.R. 7132, the Never Again International Outbreak Prevention Act.
LANGHORNE, PA—Today, June 4th, 2020, Representative Brian Fitzpatrick (PA-01) joined a bipartisan group of Members in introducing H.R. 7092, the Great American Outdoors Act.
WASHINGTON, D.C.—Today, June 4th, 2020, Representatives Brian Fitzpatrick (PA-01), Eddie Bernice Johnson (TX-30), John Joyce, M.D. (PA-13), and Lauren Underwood (IL-14) introduced the bipartisan National Healthcare Professional Appreciation Day Resolution.
Members urge DEA to mitigate the National Drug Takeback Day delay with an at-home disposal initiative amid the COVID-19 pandemic and ongoing opioid epidemic
LANGHORNE, PA - Today, May 26th, 2020, Reps.
In 2019, Fitzpatrick founded the bipartisan ALS Caucus with Reps. Crow, Calvert, and Sewell
WASHINGTON -- Today, Representatives Brian Fitzpatrick (R-PA-01), Jason Crow (D-CO-06), Ken Calvert (R-CA-42), and Terri Sewell (D-AL-07) introduced a resolution designating May as ALS Awareness Month to raise awareness about the challenges faced by ALS patients and their families.
LANGHORNE, PA—Last night, the office of Congressman Brian Fitzpatrick (PA-01) was informed by the U.S. Department of Health and Human Services (HHS) that the agency has committed an additional 200 cases of Remdesivir to be allocated to Pennsylvania from the federal stockpile.
LANGHORNE, PA—Yesterday, May 12th, 2020, Congressman Brian Fitzpatrick (PA-01) sent a letter to Speaker Pelosi and Republican Leader McCarthy highlighting solutions for dental practices and other medical professionals struggling during the coronavirus pandemic.
Officials Urge State to be Transparent about Distribution
LANGHORNE, PA—Today, May 12th, 2020, Congressman Brian Fitzpatrick (PA-01), along with state and local officials in Bucks and Montgomery counties, sent a letter to Pennsylvania Secretary of Health, Dr. Rachel Levine, regarding the availability of the clinical drug, Remdesivir.